Intellectual Property India Publishes Patent Application for Heterocyclic Oxazolidinone Compounds Having Anti-Microbial Activity, And A Process Thereof.

MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202621025964 A) filed by Mit Art, Design And Technology University on March 05, 2026, for Heterocyclic Oxazolidinone Compounds Having Anti-Microbial Activity, And A Process Thereof..

Inventors include Dr. Rahul Kadu; Khushbu Patil; and Sanjay Soni.

The application for the patent was published on October 09, 2026, under issue no. 41/2026.

Abstract: The present disclosure relates to heterocyclic oxazolidinone compounds. In particular, the oxazolidinone compounds are represented by Formula 1. The Formula 1 compounds are substituted at N3 with a heterocyclic group, not limited to the chloroaryl groups: along with amino moieties and its derivatives at C5 position. The disclosure further provides a synthesis, compositions, and therapeutic applications of heterocyclic oxazolidinone compounds in antimicrobial therapy. The synthesis is simple, scalable under mild conditions to provide high yields.

Disclaimer: Curated by HT Syndication.